Medtronic to announce financial results for its second quarter of fiscal year 2025

Medtronic, Recor win CMS transitional payment coverage for renal denervation devices

Medtronic settles pulse oximetry lawsuit alleging inaccuracies

Medtronic Symplicity Spyral RDN gains CMS TPT payment

2 Dividend Stocks to Buy for a Lifetime of Passive Income

Medtronic (MDT) Outperforms Broader Market: What You Need to Know

CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter

Edwards, Medtronic and Inari share trial data at TCT conference

Boston Scientific’s Acurate Neo2 inferior to rival TAVR valves in study

Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock

Medtronic’s Symplicity Spyral RDN system shows sustained BP reduction

Medtronic (MDT) Ascends But Remains Behind Market: Some Facts to Note